HYBRID EVENT: You can participate in person at Orlando, USA or Virtually from your home or work.

6th Edition of Nursing World Conference

October 27-29, 2022 | Orlando, USA

October 27 -29, 2022 | Orlando, Florida, USA
NWC 2022

Esther Adanna Chikwe onyejekwe

Speaker at  Nursing World Conference 2022 - Esther Adanna Chikwe onyejekwe
Arundel Lodge, United States
Title : Implementation the abnormal involuntary movement scale


Tardive dyskinesia (TD) is a movement disorder characterized by unregulated, unusual, and repetitive muscle movements of the torso, face, extremity, trunk, and other body parts that can be disruptive and have unfavorable effects on the affected individuals. The medical condition may be attributed to prolonged use of antipsychotic medications, which are associated with biochemical abnormalities in the brain. It is presumed that early screening ensures timely detection and diagnosis of TD, thereby preventing the occurrence of detrimental implications attributed to the condition. The purpose of this quality improvement (QI) quantitative quasi-experimental project was to determine if or to what extent the implementation of the AIMS metric would impact the number of patients screened for TD when compared to current practices among adult patients aged 18 to 64 years in an outpatient mental health clinic in Annapolis, Maryland over eight weeks.

Both the quantitative and qualitative methodology was used to address the clinical question and assess the relationship between implementation of AIMS and TD incidence. The pre-and post-intervention design was used to examine a cause-and-effect relationship between the independent and dependent variables in the study. Findings revealed that the implementation of the intervention was associated with a statistically significant increase in the AIMS score, with a total percentage of TD incidence reported having increased by 27%, while those patients with TD had a significantly higher AIMS score than the baseline. The findings suggest that the use of the AIMs tool by health care providers amongst adults currently taking antipsychotics was associated with increased detection of TD symptoms.